Brege Laura

SEC Form 4 insider
Mirum Pharmaceuticals, Inc. ($MIRM)
1 thesis · first seen Nov 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$MIRMSEC Form 4bearish
Brege Laura · Mirum Pharmaceuticals, Inc. · 20h agono track record yet
Sold 14,167 @ $94.21 avg · $1,334,656 · 2026-11-11

Form 4: Brege Laura sold MIRM

Brege Laura (Director at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 14,167 shares of MIRM at an average $94.21, roughly $1,334,656, in a Form 4 filed 2026-11-13.

At post $93.99Now $92.35-1.7% since postedas of Nov 9, 11:30 AM ET
View filing on SEC.gov →

End of results.